Back to GILD
Bellevue Group AG GILD Position History
Gilead Sciences, Inc. • Healthcare
Quarters held
7
Latest value
$312M
Q3 2026
Peak value
$312M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $6.5M |
| Q1 2026 | $7.2M |
| Q1 2026 | $155.8M |
| Q2 2026 | $8.3M |
| Q2 2026 | $264.4M |
| Q3 2026 | $8.6M |
| Q3 2026 | $312M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $312M | 2.09M | — | — |
| Q3 2026 | $8.6M | 57.7K | — | — |
| Q2 2026 | $264.4M | 2.09M | — | — |
| Q2 2026 | $8.3M | 65.8K | — | — |
| Q1 2026 | $155.8M | 1.12M | — | — |
| Q1 2026 | $7.2M | 51.9K | — | — |
| Q4 2025 | $6.5M | 52.8K | — | — |